10.03.12 | Insights & Interviews

The Management of Risk and Compliance: The Board's Role

On Wednesday, October 3, 2012 Morvillo Abramowitz Partners Jeremy H. Temkin and Richard F. Albert, joined by Douglas M. Lankler, Executive Vice President, Chief Compliance and Risk Officer, Pfizer, Inc., took part in a Directors & Boards webinar entitled, "The Management of Risk and Compliance: The Board’s Role." Temkin, Albert and Lankler discussed the risk and compliance responsibilities facing the Board, the elements of a well-designed compliance program, and lessons to learn based on cautionary case studies from recent headline-grabbing breakdowns.